期刊文献+

人端粒酶逆转录酶启动子调节单纯疱疹病毒胸苷激酶和人白细胞介素12融合基因肿瘤细胞特异性表达载体的构建及意义

Construction and identification of tumor cells specific expression vector of combination gene of HSV-TK and hIL-12 driven by hTERT promotor
原文传递
导出
摘要 目的构建由人端粒酶逆转录酶(hTERT)启动子调节的单纯疱疹病毒胸苷激酶基因(HSV—TK)和人白细胞介素12(hIL-12)融合基因表达载体。方法利用聚合酶链反应(PCR)分别扩增hTERT启动子基因、HSV—TK基因和hIL-12p70基因,并将其分别克隆至pShuttle载体上,合成pShuttle—hTERTp—HSV—TK—linker—IL一-12融合基因表达载体,并对所合成的载体酶切、测序检验。结果各基凶片段成功扩增,大小分别为1084、1173、1557bp,并成功联结至pShuttle载体上。对所构建新载体分别行酶切鉴定,各融合基因片段大小与预计大小相符,DNA序列测定结果显示,与目标序列完全一致,无突变发生。结论成功构建肿瘤特异性启动子调控的融合基因表达载体pShuttle—hTERTp—HSV—TK—linker—IL-12。 Objective To construct the tumor cells specific expression vector of combination gene of herpes simplex virus thymidine kinase (HSV-TK) and human inlerleukin 12 (hIL-12) driven by human telomerase reverse transcriptase (hTERT) promotor for the further research. Methods hTERTp, HSV-TK and IL-12p70 genes were amplified by using PCR separately and cloned into the vector pShuttle to establish the combination geue expression vector as pShuttle-hTERTp-HSV-TK-linker-IL-12. Subsequently, the expression vector was identified by enzyme digestion and DNA sequencing. Results The hTERTp, HSV-TK and IL-12p70 genes, which were 1084, 1173 and 1557 bp respectively, were successfully cloned into the expression vector and identified to be correct by enzyme digestion and sequencing. Conclusion The pShuttle-hTERTp-HSV-TK-linker-IL-12 combination gene expression vector was successfully constructed as prediction.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第3期305-308,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30840078)
  • 相关文献

参考文献5

二级参考文献11

  • 1Gu J, Kagawa S, Takakura M, et al. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the bax gene to cancers. Cancer Res,2000, 60 : 5359-5364.
  • 2Jian Gu,Shunsuke K,Masahiro T,et al.Tumor-specific expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.Cancer Res,2000;60(19):5359-5364.
  • 3Hahn WC.Role of telomeres and telomerase in the pathogenesis of human cancer.J Clin Oncol,2003;21(10):2034-2043.
  • 4Horikawa I,Cable PL,Afshari C,et al.Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.Cancer Res,1999;59(4):826-830.
  • 5Cong YS,Wen J,Bacchetti S.The human telomerase catalytic subunit hTERT:organization of the gene and characterization of the promoter.Hum Mol Genet,1999;8(1):137-142.
  • 6Humphreys MJ,Ghaneh P,Greenhalf W,et al.Hepatic intraarterial delivery of a retroviral vector expressing the cytosine deaminase gene,controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.Gene Ther,2001;8(16):1241-1247.
  • 7Gotoh A,Ko SC,Shirakawa T,et al.Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer.J Urol,1998;160(1):220-229.
  • 8Takakura M,Kyo S,Kanaya T,et al.Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.Cancer Res,1999;59(3):551-557.
  • 9黄君健,李杰之,林坚,蒋晓山,高朝晖,黄翠芬.人端粒酶催化亚基hTERT基因启动子的克隆[J].生物技术通讯,1999,10(3):167-170. 被引量:18
  • 10全硕,潘国宗,鲁重美,刘东远,左瑾,方福德.甲胎蛋白特异启动元件介导的肝癌靶向性基因治疗的体外实验研究[J].中国医学科学院学报,1999,21(2):111-117. 被引量:6

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部